NEW YORK STATE COMMON RETIREMENT FUND - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.8%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$185
-33.5%
27,043
+0.9%
0.00%
Q2 2023$278
+28.1%
26,811
-0.2%
0.00%
Q1 2023$217
-70.5%
26,858
-42.5%
0.00%
-100.0%
Q4 2022$736
-99.9%
46,739
-0.1%
0.00%0.0%
Q3 2022$737,000
+36.0%
46,808
+20.5%
0.00%0.0%
Q2 2022$542,000
-19.3%
38,855
-0.3%
0.00%0.0%
Q1 2022$672,000
+47.7%
38,955
+24.3%
0.00%
Q4 2021$455,000
-19.3%
31,327
-0.1%
0.00%
-100.0%
Q3 2021$564,000
-13.6%
31,347
-15.7%
0.00%0.0%
Q2 2021$653,000
+2006.5%
37,200
+25.5%
0.00%
Q1 2020$31,000
-44.6%
29,6490.0%0.00%
Q4 2019$56,000
+75.0%
29,6490.0%0.00%
Q3 2019$32,000
-50.8%
29,6490.0%0.00%
Q2 2019$65,000
-63.5%
29,6490.0%0.00%
Q1 2019$178,000
-18.7%
29,6490.0%0.00%
Q4 2018$219,000
-49.2%
29,6490.0%0.00%
-100.0%
Q3 2018$431,000
-27.2%
29,6490.0%0.00%0.0%
Q2 2018$592,000
+42.3%
29,649
+24.8%
0.00%0.0%
Q1 2018$416,000
-29.0%
23,7490.0%0.00%0.0%
Q4 2017$586,000
+5.4%
23,749
+10.2%
0.00%0.0%
Q3 2017$556,000
-13.4%
21,549
-8.9%
0.00%0.0%
Q2 2017$642,000
+68.5%
23,661
+85.1%
0.00%0.0%
Q1 2017$381,000
-10.4%
12,784
-18.3%
0.00%0.0%
Q4 2016$425,000
+16.8%
15,646
+10.1%
0.00%0.0%
Q3 2016$364,000
+73.3%
14,212
+25.2%
0.00%
Q2 2016$210,000
+356.5%
11,349
+363.4%
0.00%
Q1 2016$46,0002,4490.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders